Clinical Application of Artificial Oocyte Activation Technique (AOA) in ART
1 other identifier
interventional
400
1 country
1
Brief Summary
Oocyte activation is an imperative stage in the initiation of embryo development during the fertilization. Indeed, the entrance of sperm into the oocyte causes sequences of calcium oscillations in its cytoplasm, regulating a series of molecular events called oocyte activation. The intracytoplasmic sperm injection (ICSI) has allowed fertilization in couples with severe male factor infertility. But, there was still fertilization failure or low fertilization occurs in ICSI cycles. It has reported that insufficient of oocyte activation is the important cause of fertilization failure. Artificial oocyte activation (AOA) represents an effective technique, can restore the calcium oscillations to improve the fertilization. Here, the investigators explore the effective of different AOA methods including oocyte was injected CaCl2 or mechanical stimulated then treated with calcium ionophore.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2020
CompletedFirst Posted
Study publicly available on registry
August 20, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedSeptember 1, 2020
August 1, 2020
11 months
July 30, 2020
August 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of AOA on fertilization
Assess the normal fertilization rate (2PN rate)
12 months
Secondary Outcomes (2)
Efficacy of AOA on embryo quality
12 months
Efficacy of AOA on clinical outcome
24 months
Study Arms (3)
Standard ICSI procedure
NO INTERVENTIONa single spermatozoon was injected into the ooplasm.
Chemical oocyte activation
EXPERIMENTALAfter CaCl2 was injected, the oocytes were transferred into the calcium ionophore A23187 activation solution for two times of post-ICSI AOA.
Mechanical oocyte activation
EXPERIMENTALMechanical stimulation was done before standard ICSI procedure, then the oocytes were transferred into the calcium ionophore A23187 activation solution for two times of post-ICSI AOA.
Interventions
AOA represents an invasive non-physiological technique.
Eligibility Criteria
You may qualify if:
- The patients suffered at least one complete fertilization failure or low fertilization rate after performing standard ICSI in previous cycle. Low fertilization was defined as less than 33% fertilization rate.
- The patients suffered at least 2 cycles complete fertilization failure or low fertilization rate after performing IVF in previous cycle. Low fertilization was defined as less than 33% fertilization rate.
- The sperm of the patients has the following characteristics: globozoospermia, acrosomal deletion or small, severe head deformity, etc.
- Sperm of testicular origin and/or sperm that has been freeze-thawed.
- The sperm was PLC-ζ missing.
- The MII oocytes were IVM cultured and/or freeze-thawed.
- The patients suffered at least 2 cycles no available embryos, because of the embryo development block or fragmentation.
You may not qualify if:
- Normal fertilization IVF/ICSI cycles.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
Tangdu Hospital
Xi'an, Shaanxi, 710038, China
Study Officials
- STUDY CHAIR
Li Bo, Doctor
Reproductive Medicine Center, Tangdu Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2020
First Posted
August 20, 2020
Study Start
October 1, 2020
Primary Completion
August 31, 2021
Study Completion
August 31, 2022
Last Updated
September 1, 2020
Record last verified: 2020-08